Settlement: J&J To Pay $2.5 Billion For DePuy ASR Hip Implant Lawsuits
Posted by Marilyn McGoldrick on Nov 20, 2013 2:30:00 PM Depuy Orthopaedics, Inc., announced that it will pay approximately 2.5 billion dollars to settle claims for individuals who were implanted with the recalled Depuy ASR™ XL Acetabular Hip System or the ASR™ Hip...
Johnson & Johnson Fined $2.2 Billion: Marketed Risperdal For Off-Label Use
By Marilyn T. McGoldrick, Esq. Posted on Nov 15, 2013 Although only approved by the Food and Drug Administration for certain patients with specific psychiatric disorders, Johnson & Johnson marketed Risperdal for a variety of non-approved, “off label,” uses. This...
Reports: Johnson & Johnson Will Pay $4B In DePuy ASR Settlements
Posted by Marilyn McGoldrick on Nov 13, 2013 10:30:00 AM Today there are multiple news reports of great interest to people suffering from defective hip replacements: Johnson & Johnson’s subsidiary DePuy Orthopaedics has agreed to a tentative settlement of over 4...